These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3026018

  • 1. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC, Scoles PV, Makley JT, Jacobs MR, Blumer JL, Kalamchi A.
    Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [Abstract] [Full Text] [Related]

  • 2. Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae.
    Pressler T, Pedersen SS, Christiansen L, Szaff M, Koch C, Høiby N.
    J Antimicrob Chemother; 1986 Apr; 17(4):529-33. PubMed ID: 3011725
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
    Kulhanjian J, Dunphy MG, Hamstra S, Levernier K, Rankin M, Petru A, Azimi P.
    Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
    [Abstract] [Full Text] [Related]

  • 4. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
    Ball AP, Fox C, Ghosh D.
    J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V, Bitsi M, Theodoridis C, Saroglou I, Krikos X, Tzanetou K.
    Rev Infect Dis; 1986 Oct; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children.
    Ginsburg CM, McCracken GH, Olsen K, Petruska M.
    J Antimicrob Chemother; 1985 Mar; 15(3):345-51. PubMed ID: 2987174
    [Abstract] [Full Text] [Related]

  • 9. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
    Wald E, Reilly JS, Bluestone CD, Chiponis D.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S617-9. PubMed ID: 3026014
    [Abstract] [Full Text] [Related]

  • 10. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
    Löffler L, Bauernfeind A, Keyl W, Hoffstedt B, Piergies A, Lenz W.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S593-8. PubMed ID: 3026009
    [Abstract] [Full Text] [Related]

  • 11. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR, Girard D, Cimochowski C, Faiella J, Retsema JA, Lynch JE.
    Rev Infect Dis; 1986 Mar; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [Abstract] [Full Text] [Related]

  • 12. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
    Chang ST, Chung HY, Pai SD, Lee JH.
    Diagn Microbiol Infect Dis; 1989 Mar; 12(4 Suppl):175S-178S. PubMed ID: 2686917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sultamicillin (sulbactam/ampicillin) versus amoxycillin in the treatment of acute otitis media in children.
    Rodriguez WJ, Khan WH, Sait T, Chhabra OP, Guarinello A, Smith AW, Ahmad S.
    J Int Med Res; 1990 Mar; 18 Suppl 4():78D-84D. PubMed ID: 2282972
    [Abstract] [Full Text] [Related]

  • 20. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L, Boghossian J, Pollak R, Caputo W, Dana A, Gray S, Wu D.
    Surg Infect (Larchmt); 2005 Mar; 6(1):27-40. PubMed ID: 15865549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.